Stokes, Leanne ORCID: https://orcid.org/0000-0003-4013-6781, Layhadi, Janice A., Bibic, Lucka, Dhuna, Kshitija and Fountain, Samuel J. ORCID: https://orcid.org/0000-0002-6028-0548 (2017) P2X4 receptor function in the nervous system and current breakthroughs in pharmacology. Frontiers in Pharmacology, 8. ISSN 1663-9812
Preview |
PDF (fphar-08-00291)
- Published Version
Available under License Creative Commons Attribution. Download (796kB) | Preview |
Abstract
ATP is a well-known extracellular signalling molecule and neurotransmitter known to activate purinergic P2X receptors. Information has been elucidated about the structure and gating of P2X channels following the determination of the crystal structure of P2X4 (zebrafish), however there is still much to discover regarding the role of this receptor in the central nervous system (CNS). In this review we provide an overview of what is known about P2X4 expression in the CNS and discuss evidence for pathophysiological roles in neuroinflammation and neuropathic pain. Recent advances in the development of pharmacological tools including selective antagonists (5-BDBD, PSB-12062, BX430) and positive modulators (ivermectin, avermectins, divalent cations) of P2X4 will be discussed.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | atp,p2x receptor,p2x4 receptor,ivermectin,microglial cells,neuroinflammation,pain,pharmacology |
Faculty \ School: | Faculty of Science > School of Pharmacy (former - to 2024) Faculty of Science > School of Biological Sciences Faculty of Science |
UEA Research Groups: | Faculty of Science > Research Groups > Cells and Tissues Faculty of Science > Research Groups > Molecular and Tissue Pharmacology |
Depositing User: | Pure Connector |
Date Deposited: | 13 May 2017 05:05 |
Last Modified: | 25 Sep 2024 12:45 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/63500 |
DOI: | 10.3389/fphar.2017.00291 |
Downloads
Downloads per month over past year
Actions (login required)
View Item |